SCHEMBL6219263

SCHEMBL6219263

COc1cccc(-c2nc(-c3cccs3)nc3sc(C(=O)NC(C)C)c(N)c23)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.62
HPGD P15428 5/20 0.62
NPSR1 Q6W5P4 4/20 0.62
KMT2A Q03164 3/20 0.62
ALDH1A1 P00352 3/20 0.62
MEN1 O00255 2/20 0.62
LHCGR P22888 3/20 0.54
TSHR P16473 1/20 0.54
BRAF P15056 1/20 0.51
PDE4A P27815 1/20 0.51
PDE4B Q07343 1/20 0.51
PDE4C Q08493 1/20 0.51
PDE4D Q08499 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.47
LMNA P02545 2/20 0.47
CRHBP P24387 2/20 0.47
CRHR2 Q13324 2/20 0.47
TLR9 Q9NR96 2/20 0.47
CHRM4 P08173 2/20 0.46
KDM4E B2RXH2 5/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6216776 0.88 LHCGR (0.58) MAPTHPGDNPSR1KMT2AALDH1A1
SCHEMBL6219498 0.85 MAPT (0.60) MAPTHPGDNPSR1KMT2AALDH1A1
SCHEMBL6218118 0.84 LHCGR (0.53) MAPTHPGDNPSR1KMT2AALDH1A1
SCHEMBL6427025 0.82 LHCGR (0.78) MAPTHPGDNPSR1KMT2AALDH1A1
SCHEMBL6214563 0.81 PLAUR (0.53) MAPTHPGDKMT2AALDH1A1MEN1
SCHEMBL5026100 0.79 LHCGR (0.57) MAPTHPGDNPSR1KMT2AALDH1A1
SCHEMBL6215868 0.78 HPGD (0.85) MAPTHPGDNPSR1KMT2AALDH1A1
SCHEMBL6220509 0.77 MAPT (1.00) MAPTHPGDNPSR1KMT2AALDH1A1
SCHEMBL5026164 0.77 HPGD (0.50) MAPTHPGDNPSR1KMT2AALDH1A1
SCHEMBL5026126 0.77 BRAF (0.59) MAPTHPGDNPSR1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1171443-B1 BICYCLIC HETEROAROMATIC COMPOUNDS USEFUL AS LH AGONISTS AKZO NOBEL NV (NL) 2005-07-13 EP disclosed
US-6841553-B2 Bicyclic heteroaromatic compounds useful as LH agonists AKZO NOBEL N.V. (NL) 2005-01-11 US disclosed
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists MERCK SHARP & DOHME B.V. (NL) 2003-11-13 US disclosed
US-6569863-B1 Luteinizing hormone (LH) agonists for controlling fertility AKZO NOBEL NV (NL) 2003-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists LHCGR, GNRHR, FSHR MAPT 4619/4885HPGD 1313/4885NPSR1 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.